Carolinas HealthCare System

Research and Clinical Trials

Title   Gilead 0130
Brief Description   This trial is looking at the safety, tolerability and effectiveness of a medication named cobisitat in HIV postitive individuals. Both naïve (never been on therapy) and treatment experienced patients are being considered. This trial will be looking at the effectiveness of the combination of Darunavir with cobisistat with an investigator defined backbone. The duration of this trial is at least 48 weeks or approximately one year.
Who may be Eligible   Any HIV positive patient may be considered for the study. Treatment-experienced patients must have an undectable viral load for at least 6 months prior to screening
Specialty/Disorder   HIV
IRB Number   CHS1-11-461
Principal Investigator   Johnson, Marc
For More Information, Contact   Jessica  A.  Kearney-Bryan , RN
Phone:  (704) 355-0244  Fax:  (704) 446-7641 
Email:  jessica.kearney-bryan@carolinashealthcare.org
Address:  3rd Floor
Myers Park Clinic
1350 South King's Drive
Charlotte, NC 28207
About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity & Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy Policy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.